These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7174514)

  • 1. Studies on the OA-6129 group of antibiotics, new carbapenem compounds. II. In vitro evaluation.
    Sakamoto M; Kojima I; Okabe M; Fukagawa Y; Ishikura T
    J Antibiot (Tokyo); 1982 Oct; 35(10):1264-70. PubMed ID: 7174514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms.
    Sakamoto M; Ishikura T; Fukagawa Y
    J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactamase inhibitory activities and synergistic effects of 5,6-cis-carbapenem antibiotics.
    Okonogi K; Harada S; Shinagawa S; Imada A; Kuno M
    J Antibiot (Tokyo); 1982 Aug; 35(8):963-71. PubMed ID: 6982889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial phosphorylation of the OA-6129 group of carbapenem compounds.
    Kubo K; Ishikura T; Fukagawa Y
    J Antibiot (Tokyo); 1985 Mar; 38(3):333-9. PubMed ID: 3839225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PS-6 and PS-7, new beta-lactam antibiotics. In vitro and in vivo evaluation.
    Sakamoto M; Shibamoto N; Iguchi H; Okamura K; Hori S; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1980 Oct; 33(10):1138-45. PubMed ID: 7451364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological studies on carbapenem antibiotics. I. Metabolism of PS-5 in animal tissues.
    Shibamoto N; Sakamoto M; Iguchi H; Tone H; Fukagawa Y; Ishikura T
    J Antibiot (Tokyo); 1982 Jun; 35(6):721-8. PubMed ID: 6811538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and pharmacokinetic properties of the carbapenems.
    Wise R
    Antimicrob Agents Chemother; 1986 Sep; 30(3):343-9. PubMed ID: 3535659
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2006].
    Yamaguchi K; Ishii Y; Iwata M; Watanabe N; Uehara N; Yasujima M; Kasai T; Suwabe A; Yamahata K; Kaku M; Kanemitsu K; Imafuku Y; Nishiyama K; Murakami M; Yomoda S; Taniguchi N; Yamada T; Nomura F; Watanabe M; Kanno H; Aihara M; Maesaki S; Hashikita G; Kondo S; Misawa S; Horiuchi H; Tazawa Y; Nakashima H; Takemura H; Okada M; Yamazaki F; Horii T; Maekawa M; Baba H; Ishigo S; Fujita N; Komori T; Ichiyama S; Iinuma Y; Maeda S; Yamanaka K; Murata Y; Matsuo S; Kohno H; Kinoshita S; Fujita J; Negayama K; Murase M; Miyamoto H; Kusano N; Mihara E; Itaha H; Ono J; Yoshimura H; Yanagihara K; Matsuda J; Saikawa T; Hiramatsu K
    Jpn J Antibiot; 2007 Dec; 60(6):344-77. PubMed ID: 18447206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological studies on carbapenem antibiotics. III. Chemical structure of PS-5D III, the primary renal metabolite of PS-5.
    Shibamoto N; Yoshioka T; Sakamoto M; Fukagawa Y; Ishikura T
    J Antibiot (Tokyo); 1982 Jun; 35(6):736-41. PubMed ID: 6981638
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the biosynthesis of carbapenem antibiotics. I. Biosynthetic significance of the OA-6129 group of carbapenem compounds as the direct precursors for PS-5, epithienamycins A and C and MM 17880.
    Fukagawa Y; Okabe M; Azuma S; Kojima I; Ishikura T; Kubo K
    J Antibiot (Tokyo); 1984 Nov; 37(11):1388-93. PubMed ID: 6511666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-19393 E5, a new carbapenem antibiotic. Fermentation, isolation and structure.
    Harada S; Nozaki Y; Shinagawa S; Kitano K
    J Antibiot (Tokyo); 1982 Aug; 35(8):957-62. PubMed ID: 6815148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2012].
    Yamaguchi K; Ishii Y; Tateda K; Iwata M; Watanabe N; Shinagawa M; Kayaba H; Kimura M; Suwabe A; Kaku M; Abe Y; Kanemitsu K; Taniguchi N; Murakami M; Maesaki S; Kawamura T; Nomura F; Watanabe M; Kanno H; Horiuchi H; Tazawa Y; Kondo S; Misawa S; Takemura H; Nakashima H; Matsuto T; Fujimoto Y; Ishigo S; Gotoh H; Watanabe O; Yagi T; Shimaoka N; Mikamo H; Yamagishi Y; Fujita N; Komori T; Ichiyama S; Kawano S; Nakayama A; Nakamura F; Kohno H; Fukuda S; Kusano N; Nose M; Yokozaki M; Onodera M; Murao K; Negayama K; Nishimiya T; Miyamoto H; Matsunaga A; Yoshimura H; Kohno S; Yanagihara K; Hiramatsu K
    Jpn J Antibiot; 2014 Apr; 67(2):73-107. PubMed ID: 24956909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of SF-2103A, a novel carbapenem antibiotic, as a beta-lactamase inhibitor.
    Niwa T; Yoshida T; Tamura A; Kazuno Y; Inouye S; Ito T; Kojima M
    J Antibiot (Tokyo); 1986 Jul; 39(7):943-55. PubMed ID: 3019978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase.
    Okamura K; Sakamoto M; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Apr; 32(4):280-6. PubMed ID: 381269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228.
    Reck F; Bermingham A; Blais J; Capka V; Cariaga T; Casarez A; Colvin R; Dean CR; Fekete A; Gong W; Growcott E; Guo H; Jones AK; Li C; Li F; Lin X; Lindvall M; Lopez S; McKenney D; Metzger L; Moser HE; Prathapam R; Rasper D; Rudewicz P; Sethuraman V; Shen X; Shaul J; Simmons RL; Tashiro K; Tang D; Tjandra M; Turner N; Uehara T; Vitt C; Whitebread S; Yifru A; Zang X; Zhu Q
    Bioorg Med Chem Lett; 2018 Feb; 28(4):748-755. PubMed ID: 29336873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research on new beta-lactam antibiotics; penem and carbapenem].
    Sugimura Y; Hiraoka T
    Yakugaku Zasshi; 1987 Mar; 107(3):175-91. PubMed ID: 3298614
    [No Abstract]   [Full Text] [Related]  

  • 20. Asparenomycin A, a new carbapenem antibiotic.
    Tanaka K; Shoji J; Terui Y; Tsuji N; Kondo E; Mayama M; Kawamura Y; Hattori T; Matsumoto K; Yoshida T
    J Antibiot (Tokyo); 1981 Jul; 34(7):909-11. PubMed ID: 6974725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.